"Intra-Abdominal Fat" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
Fatty tissue inside the ABDOMINAL CAVITY, including visceral fat and retroperitoneal fat. It is the most metabolically active fat in the body and easily accessible for LIPOLYSIS. Increased visceral fat is associated with metabolic complications of OBESITY.
- Intra-Abdominal Fat
- Fats, Intra-Abdominal
- Intra Abdominal Fat
- Intra-Abdominal Fats
- Fat, Intra-Abdominal
- Fat, Intra Abdominal
- Intra-Abdominal Adipose Tissue
- Adipose Tissue, Intra-Abdominal
- Intra Abdominal Adipose Tissue
- Retroperitoneal Fat
- Fat, Retroperitoneal
- Fats, Retroperitoneal
- Retroperitoneal Fats
- Retroperitoneal Adipose Tissue
- Adipose Tissue, Retroperitoneal
- Visceral Fat
- Fat, Visceral
- Fats, Visceral
- Visceral Fats
- Abdominal Visceral Fat
- Abdominal Visceral Fats
- Fat, Abdominal Visceral
- Fats, Abdominal Visceral
- Visceral Adipose Tissue
- Adipose Tissue, Visceral
Below are MeSH descriptors whose meaning is more general than "Intra-Abdominal Fat".
Below are MeSH descriptors whose meaning is more specific than "Intra-Abdominal Fat".
This graph shows the total number of publications written about "Intra-Abdominal Fat" by people in this website by year, and whether "Intra-Abdominal Fat" was a major or minor topic of these publications.
To see the data from this visualization as text, click here.
|Year||Major Topic||Minor Topic||Total|
To return to the timeline, click here.
Below are the most recent publications written about "Intra-Abdominal Fat" by people in Profiles.
Xu F, Earp JE, Blissmer BJ, Lofgren IE, Delmonico MJ, Greene GW. The Demographic Specific Abdominal Fat Composition and Distribution Trends in US Adults from 2011 to 2018. Int J Environ Res Public Health. 2022 09 24; 19(19).
Meredith-Jones K, Taylor R, Brown R, Cooke R, Vlietstra L, Manning P, Poulton R, Haszard J. Age- and sex-specific visceral fat reference cutoffs and their association with cardio-metabolic risk. Int J Obes (Lond). 2021 04; 45(4):808-817.
Pienta MJ, Zhang P, Derstine BA, Enchakalody B, Weir WB, Grenda T, Goulson R, Reddy RM, Chang AC, Wang SC, Lin J. Analytic Morphomics Predict Outcomes After Lung Transplantation. Ann Thorac Surg. 2018 Feb; 105(2):399-405.
Delivanis DA, Iñiguez-Ariza NM, Zeb MH, Moynagh MR, Takahashi N, McKenzie TJ, Thomas MA, Gogos C, Young WF, Bancos I, Kyriazopoulou V. Impact of hypercortisolism on skeletal muscle mass and adipose tissue mass in patients with adrenal adenomas. Clin Endocrinol (Oxf). 2018 02; 88(2):209-216.
Dobrian AD, Hatcher MA, Brotman JJ, Galkina EV, Taghavie-Moghadam P, Pei H, Haynes BA, Nadler JL. STAT4 contributes to adipose tissue inflammation and atherosclerosis. J Endocrinol. 2015 Oct; 227(1):13-24.
Lieb DC, Brotman JJ, Hatcher MA, Aye MS, Cole BK, Haynes BA, Wohlgemuth SD, Fontana MA, Beydoun H, Nadler JL, Dobrian AD. Adipose tissue 12/15 lipoxygenase pathway in human obesity and diabetes. J Clin Endocrinol Metab. 2014 Sep; 99(9):E1713-20.
Fain JN, Cheema P, Tichansky DS, Madan AK. Stimulation of human omental adipose tissue lipolysis by growth hormone plus dexamethasone. Mol Cell Endocrinol. 2008 Nov 25; 295(1-2):101-5.
Muzumdar R, Allison DB, Huffman DM, Ma X, Atzmon G, Einstein FH, Fishman S, Poduval AD, McVei T, Keith SW, Barzilai N. Visceral adipose tissue modulates mammalian longevity. Aging Cell. 2008 Jun; 7(3):438-40.
Duffy D, Rader D. Endocannabinoid antagonism: blocking the excess in the treatment of high-risk abdominal obesity. Trends Cardiovasc Med. 2007 Feb; 17(2):35-43.
Fain JN, Tichansky DS, Madan AK. Transforming growth factor beta1 release by human adipose tissue is enhanced in obesity. Metabolism. 2005 Nov; 54(11):1546-51.